Potentiation of apoptosis by monoclonal antibodies

Details Potentiation of apoptosis by monoclonal antibodies Potentiation of apoptosis by monoclonal antibodies

G - Physics

01

N

G01N 33/53 (2006.01) A61K 39/395 (2006.01) A61P 7/04 (2006.01) A61P 9/00 (2006.01) A61P 21/00 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01) C12Q 1/00 (2006.01)

Patent

CA 2633331

The present invention relates to the use of a composition of anti-MLA-DR antibodies expressed in cell line YB210, the fucose content of which is less than 65%, for the in vitro induction of apoptosis.

La présente invention se rapporte à l'utilisation d'une composition d'anticorps anti MLA-DR exprimés dans la ligne YB210, dont la teneur en fucose est inférieure à 65% pour induire in vitro l'apoptose.

Affiliated with

Also associated with

Rating

Potentiation of apoptosis by monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Potentiation of apoptosis by monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potentiation of apoptosis by monoclonal antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1514865